Legal & General Group PLC Dyne Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $431 Billion
  • Q3 2025

A detailed history of Legal & General Group PLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 107,975 shares of DYN stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107,975
Previous 78,533 37.49%
Holding current value
$2.03 Million
Previous $747,000 82.73%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$8.18 - $14.22 $240,835 - $418,665
29,442 Added 37.49%
107,975 $1.37 Million
Q2 2025

Aug 12, 2025
BUY
$6.81 - $14.78 $68,508 - $148,686
10,060 Added 14.69%
78,533 $747,000
Q1 2025

May 15, 2025
BUY
$10.46 - $25.46 $83 - $203
8 Added 0.01%
68,473 $716,000
Q4 2024

Feb 13, 2025
SELL
$23.56 - $35.55 $1.02 Million - $1.54 Million
-43,192 Reduced 38.68%
68,465 $1.61 Million
Q3 2024

Feb 28, 2025
BUY
$31.94 - $47.04 $1.21 Million - $1.79 Million
37,982 Added 55.48%
106,447 $3.82 Million
Q3 2024

Nov 14, 2024
BUY
$31.94 - $47.04 $1.47 Million - $2.17 Million
46,113 Added 70.35%
111,657 $4.01 Million
Q2 2024

May 29, 2025
BUY
$23.65 - $35.63 $383,910 - $578,381
16,233 Added 36.81%
60,334 $2.13 Million
Q2 2024

Aug 14, 2024
BUY
$23.65 - $35.63 $507,126 - $764,014
21,443 Added 48.62%
65,544 $2.31 Million
Q1 2024

May 29, 2025
SELL
$13.06 - $29.18 $318,298 - $711,174
-24,372 Reduced 35.59%
44,101 $1.25 Million
Q1 2024

May 14, 2024
BUY
$13.06 - $29.18 $258,940 - $578,551
19,827 Added 81.68%
44,101 $1.25 Million
Q4 2023

May 29, 2025
SELL
$6.62 - $13.64 $292,597 - $602,874
-44,199 Reduced 64.55%
24,274 $322,000
Q4 2023

Feb 15, 2024
BUY
$6.62 - $13.64 $1,204 - $2,482
182 Added 0.76%
24,274 $322,000
Q3 2023

Nov 14, 2023
SELL
$8.6 - $12.18 $3,508 - $4,969
-408 Reduced 1.67%
24,092 $215,000
Q2 2023

Aug 14, 2023
BUY
$8.53 - $14.28 $117,679 - $197,006
13,796 Added 128.89%
24,500 $275,000
Q1 2023

May 15, 2023
BUY
$10.88 - $15.0 $3,068 - $4,230
282 Added 2.71%
10,704 $123,000
Q3 2022

Nov 14, 2022
SELL
$7.2 - $15.17 $16,812 - $35,421
-2,335 Reduced 18.3%
10,422 $133,000
Q2 2022

Aug 22, 2022
BUY
$4.36 - $10.5 $20,836 - $50,179
4,779 Added 59.9%
12,757 $88,000
Q3 2021

Nov 15, 2021
BUY
$15.6 - $21.46 $71,401 - $98,222
4,577 Added 134.58%
7,978 $129,000
Q2 2021

Aug 12, 2021
BUY
$15.94 - $22.33 $26,858 - $37,626
1,685 Added 98.19%
3,401 $71,000
Q1 2021

May 17, 2021
BUY
$14.0 - $29.3 $3,346 - $7,002
239 Added 16.18%
1,716 $27,000
Q4 2020

Feb 12, 2021
BUY
$16.81 - $23.94 $16,507 - $23,509
982 Added 198.38%
1,477 $31,000
Q3 2020

Nov 13, 2020
BUY
$20.0 - $23.9 $9,900 - $11,830
495 New
495 $10,000

Others Institutions Holding DYN

# of Institutions
227
Shares Held
148M
Call Options Held
184K
Put Options Held
243K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $975M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email